{"id":19982,"date":"2024-06-12T16:09:24","date_gmt":"2024-06-12T16:09:24","guid":{"rendered":"https:\/\/beyondtype2.org\/resources\/fda-autoriza-mcg-venta-libre\/"},"modified":"2024-12-09T18:45:10","modified_gmt":"2024-12-09T18:45:10","slug":"fda-autoriza-mcg-venta-libre","status":"publish","type":"resources","link":"https:\/\/beyondtype1.org\/es\/fda-autoriza-mcg-venta-libre\/","title":{"rendered":"La FDA autoriza dos medidores continuos de glucosa de venta libre"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Laboratorios Abbott <\/span><a href=\"https:\/\/abbott.mediaroom.com\/2024-06-10-Abbott-Receives-U-S-FDA-Clearance-for-Two-New-Over-the-Counter-Continuous-Glucose-Monitoring-Systems\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">anunci&oacute; el 10 de junio de 2024<\/span><\/a><span style=\"font-weight: 400;\"> que la Administraci&oacute;n de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en ingl&eacute;s) autoriz&oacute; dos nuevos dispositivos de <\/span><a href=\"https:\/\/beyondtype1.org\/es\/tabla-mcg-beyond-type-1\/\"><span style=\"font-weight: 400;\">medici&oacute;n continua de glucosa (<\/span><i><span style=\"font-weight: 400;\">MCG<\/span><\/i><span style=\"font-weight: 400;\">)<\/span><\/a><span style=\"font-weight: 400;\"> de venta libre.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Estos dos dispositivos, uno dirigido a consumidores preocupados por su salud y el otro a personas con diabetes, siguen el modelo del FreeStyle Libre de Abbott, que se vende por m&aacute;s de mil millones de d&oacute;lares al a&ntilde;o y est&aacute; disponible con receta para personas con diabetes.<\/span><\/p>\n<h3><b>&iquest;QU&Eacute; ES EL LIBRE RIO?<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Un nuevo MCG de venta libre llamado Libre Rio est&aacute; dirigido a personas mayores de 18 a&ntilde;os con diabetes tipo 2 que no se administran insulina y que normalmente manejan su condici&oacute;n modificando su estilo de vida.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">El Libre Rio es el primer sistema MCG de venta libre con un rango de medici&oacute;n de 40 a 400 mg\/dL, lo que permite medir episodios de niveles de glucosa en sangre extremadamente bajos o altos.<\/span><\/p>\n<p><a href=\"https:\/\/www.reuters.com\/business\/healthcare-pharmaceuticals\/us-fda-clears-abbotts-continuous-glucose-monitors-over-the-counter-use-2024-06-10\/\" target=\"_blank\" rel=\"noopener noreferrer\"><span style=\"font-weight: 400;\">Seg&uacute;n Shagun Singh, analista de RBC Capital Markets,<\/span><\/a><span style=\"font-weight: 400;\"> 24,5 millones de personas con diabetes tipo 2 que no se administran insulina ahora tienen acceso a un MCG gracias a la aprobaci&oacute;n de Libre Rio por parte de la FDA.<\/span><\/p>\n<h3><b>&iquest;QU&Eacute; ES LINGO?<\/b><\/h3>\n<p><span style=\"font-weight: 400;\">Lingo es un MCG de venta libre para quienes no tienen diabetes y desean mejorar su salud y bienestar.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Lingo est&aacute; dise&ntilde;ado para consumidores mayores de 18 a&ntilde;os que buscan mejorar su salud y bienestar general.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Lingo ayudar&aacute; a monitorear el nivel de glucosa en sangre y puede ayudar a comprender los efectos de diversos h&aacute;bitos alimentarios, ejercicio, sue&ntilde;o y estr&eacute;s en los niveles de glucosa en sangre en tiempo real.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Durante dos semanas, el sensor Lingo, que se lleva en la parte superior del brazo, transmite continuamente lecturas de glucosa a una aplicaci&oacute;n de entrenamiento para tel&eacute;fonos inteligentes.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Libre Rio y Lingo competir&aacute;n con Stelo de Dexcom, <\/span><span style=\"font-weight: 400;\">que en marzo de <\/span><span style=\"font-weight: 400;\">2024 se convirti&oacute; en el primer medidor continuo de glucosa de venta libre aprobado por la FDA.<\/span><\/p>\n<hr>\n<p style=\"text-align: center;\"><i><span style=\"font-weight: 400;\">La cobertura de noticias del equipo de Beyond Type 1 se realiza independientemente de cualquier asociaci&oacute;n de contenido.<\/span><\/i><\/p>\n<p style=\"text-align: center;\"><i><span style=\"font-weight: 400;\">Beyond Type 1 mantiene el control editorial total de todo el contenido publicado en nuestras plataformas.<\/span><\/i><\/p>\n\n","protected":false},"excerpt":{"rendered":"<p>Laboratorios Abbott anunci&oacute; el 10 de junio de 2024 que la Administraci&oacute;n de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en ingl&eacute;s) autoriz&oacute; dos nuevos dispositivos de medici&oacute;n continua de glucosa (MCG) de venta libre. Estos dos dispositivos, uno dirigido a consumidores preocupados por su salud y el otro a personas [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":19984,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-19982","resources","type-resources","status-publish","has-post-thumbnail","hentry","diabetes-types-tipo-1","diabetes-types-tipo-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>La FDA autoriza dos medidores continuos de glucosa de venta libre | Beyond Type 1<\/title>\n<meta name=\"description\" content=\"Los nuevos MCG de venta libre de Abbott, Libre Rio para la DT2 y Lingo para el bienestar, obtuvieron la autorizaci\u00f3n de la FDA.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/beyondtype1.org\/es\/fda-autoriza-mcg-venta-libre\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La FDA autoriza dos medidores continuos de glucosa de venta libre | Beyond Type 1\" \/>\n<meta property=\"og:description\" content=\"Los nuevos MCG de venta libre de Abbott, Libre Rio para la DT2 y Lingo para el bienestar, obtuvieron la autorizaci\u00f3n de la FDA.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/beyondtype1.org\/es\/fda-autoriza-mcg-venta-libre\/\" \/>\n<meta property=\"og:site_name\" content=\"Beyond Type 1\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/beyondtype1\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-09T18:45:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-ABBOTT-FDA-CLEARANCE-OTC-GLUCOSE-MONITORS-HEADER.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2048\" \/>\n\t<meta property=\"og:image:height\" content=\"733\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@BeyondType1\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/beyondtype1.org\/es\/fda-autoriza-mcg-venta-libre\/\",\"url\":\"https:\/\/beyondtype1.org\/es\/fda-autoriza-mcg-venta-libre\/\",\"name\":\"La FDA autoriza dos medidores continuos de glucosa de venta libre | Beyond Type 1\",\"isPartOf\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/fda-autoriza-mcg-venta-libre\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/fda-autoriza-mcg-venta-libre\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-ABBOTT-FDA-CLEARANCE-OTC-GLUCOSE-MONITORS-HEADER.jpg\",\"datePublished\":\"2024-06-12T16:09:24+00:00\",\"dateModified\":\"2024-12-09T18:45:10+00:00\",\"description\":\"Los nuevos MCG de venta libre de Abbott, Libre Rio para la DT2 y Lingo para el bienestar, obtuvieron la autorizaci\u00f3n de la FDA.\",\"breadcrumb\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/fda-autoriza-mcg-venta-libre\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/beyondtype1.org\/es\/fda-autoriza-mcg-venta-libre\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/beyondtype1.org\/es\/fda-autoriza-mcg-venta-libre\/#primaryimage\",\"url\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-ABBOTT-FDA-CLEARANCE-OTC-GLUCOSE-MONITORS-HEADER.jpg\",\"contentUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-ABBOTT-FDA-CLEARANCE-OTC-GLUCOSE-MONITORS-HEADER.jpg\",\"width\":2048,\"height\":733},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/beyondtype1.org\/es\/fda-autoriza-mcg-venta-libre\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/beyondtype1.org\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"La FDA autoriza dos medidores continuos de glucosa de venta libre\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#website\",\"url\":\"https:\/\/beyondtype1.org\/es\/\",\"name\":\"Beyond Type 1\",\"description\":\"Beyond Type 1 is the largest diabetes org online, funding advocacy, education and cure research.\",\"publisher\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/beyondtype1.org\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#organization\",\"name\":\"Beyond Type 1\",\"url\":\"https:\/\/beyondtype1.org\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg\",\"contentUrl\":\"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg\",\"width\":56,\"height\":56,\"caption\":\"Beyond Type 1\"},\"image\":{\"@id\":\"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/beyondtype1\",\"https:\/\/x.com\/BeyondType1\",\"http:\/\/instagram.com\/BeyondType1\/\",\"https:\/\/www.youtube.com\/c\/BeyondType1\",\"https:\/\/www.tiktok.com\/@beyondtype1\",\"https:\/\/www.linkedin.com\/company\/beyond-type1\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"La FDA autoriza dos medidores continuos de glucosa de venta libre | Beyond Type 1","description":"Los nuevos MCG de venta libre de Abbott, Libre Rio para la DT2 y Lingo para el bienestar, obtuvieron la autorizaci\u00f3n de la FDA.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/beyondtype1.org\/es\/fda-autoriza-mcg-venta-libre\/","og_locale":"es_ES","og_type":"article","og_title":"La FDA autoriza dos medidores continuos de glucosa de venta libre | Beyond Type 1","og_description":"Los nuevos MCG de venta libre de Abbott, Libre Rio para la DT2 y Lingo para el bienestar, obtuvieron la autorizaci\u00f3n de la FDA.","og_url":"https:\/\/beyondtype1.org\/es\/fda-autoriza-mcg-venta-libre\/","og_site_name":"Beyond Type 1","article_publisher":"https:\/\/www.facebook.com\/beyondtype1","article_modified_time":"2024-12-09T18:45:10+00:00","og_image":[{"width":2048,"height":733,"url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-ABBOTT-FDA-CLEARANCE-OTC-GLUCOSE-MONITORS-HEADER.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@BeyondType1","twitter_misc":{"Tiempo de lectura":"2 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/beyondtype1.org\/es\/fda-autoriza-mcg-venta-libre\/","url":"https:\/\/beyondtype1.org\/es\/fda-autoriza-mcg-venta-libre\/","name":"La FDA autoriza dos medidores continuos de glucosa de venta libre | Beyond Type 1","isPartOf":{"@id":"https:\/\/beyondtype1.org\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/beyondtype1.org\/es\/fda-autoriza-mcg-venta-libre\/#primaryimage"},"image":{"@id":"https:\/\/beyondtype1.org\/es\/fda-autoriza-mcg-venta-libre\/#primaryimage"},"thumbnailUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-ABBOTT-FDA-CLEARANCE-OTC-GLUCOSE-MONITORS-HEADER.jpg","datePublished":"2024-06-12T16:09:24+00:00","dateModified":"2024-12-09T18:45:10+00:00","description":"Los nuevos MCG de venta libre de Abbott, Libre Rio para la DT2 y Lingo para el bienestar, obtuvieron la autorizaci\u00f3n de la FDA.","breadcrumb":{"@id":"https:\/\/beyondtype1.org\/es\/fda-autoriza-mcg-venta-libre\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/beyondtype1.org\/es\/fda-autoriza-mcg-venta-libre\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/beyondtype1.org\/es\/fda-autoriza-mcg-venta-libre\/#primaryimage","url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-ABBOTT-FDA-CLEARANCE-OTC-GLUCOSE-MONITORS-HEADER.jpg","contentUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2024\/11\/BT1-ABBOTT-FDA-CLEARANCE-OTC-GLUCOSE-MONITORS-HEADER.jpg","width":2048,"height":733},{"@type":"BreadcrumbList","@id":"https:\/\/beyondtype1.org\/es\/fda-autoriza-mcg-venta-libre\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/beyondtype1.org\/es\/"},{"@type":"ListItem","position":2,"name":"La FDA autoriza dos medidores continuos de glucosa de venta libre"}]},{"@type":"WebSite","@id":"https:\/\/beyondtype1.org\/es\/#website","url":"https:\/\/beyondtype1.org\/es\/","name":"Beyond Type 1","description":"Beyond Type 1 is the largest diabetes org online, funding advocacy, education and cure research.","publisher":{"@id":"https:\/\/beyondtype1.org\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/beyondtype1.org\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/beyondtype1.org\/es\/#organization","name":"Beyond Type 1","url":"https:\/\/beyondtype1.org\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/","url":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg","contentUrl":"https:\/\/beyondtype1.org\/wp-content\/uploads\/2025\/08\/header-logo.svg","width":56,"height":56,"caption":"Beyond Type 1"},"image":{"@id":"https:\/\/beyondtype1.org\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/beyondtype1","https:\/\/x.com\/BeyondType1","http:\/\/instagram.com\/BeyondType1\/","https:\/\/www.youtube.com\/c\/BeyondType1","https:\/\/www.tiktok.com\/@beyondtype1","https:\/\/www.linkedin.com\/company\/beyond-type1\/"]}]}},"_links":{"self":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources\/19982","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/types\/resources"}],"author":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/comments?post=19982"}],"version-history":[{"count":0,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/resources\/19982\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/media\/19984"}],"wp:attachment":[{"href":"https:\/\/beyondtype1.org\/es\/wp-json\/wp\/v2\/media?parent=19982"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}